{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T19:06:36Z","timestamp":1748027196159,"version":"3.38.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.josat.2025.209625","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T17:22:56Z","timestamp":1737998576000},"page":"209625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The impact of buprenorphine prescriber data on geospatial access to treatment in HEALing Communities Study communities, 2022"],"prefix":"10.1016","volume":"171","author":[{"given":"Daniel R.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikhar","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Silwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gia","family":"Barboza-Salerno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeeta","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"2023 NSDUH Detailed Tables","key":"10.1016\/j.josat.2025.209625_bb0005"},{"key":"10.1016\/j.josat.2025.209625_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209193","article-title":"Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S","volume":"156","author":"Amiri","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"6, Supplement 3","key":"10.1016\/j.josat.2025.209625_bb0015","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.amepre.2018.02.006","article-title":"Prescribing practices of rural physicians waivered to prescribe buprenorphine","volume":"54","author":"Andrilla","year":"2018","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209625_bb0020","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/08897077.2022.2060430","article-title":"Accuracy of publicly-listed Locator information for buprenorphine waivered practitioners and opioid treatment programs in the US, 2020","volume":"43","author":"Barenie","year":"2022","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2025.209625_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M18-3457","article-title":"Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality","volume":"171","author":"Beetham","year":"2019","journal-title":"Annals of Internal Medicine"},{"author":"Buprenorphine Treatment Practitioner Locator","key":"10.1016\/j.josat.2025.209625_bb0030"},{"key":"10.1016\/j.josat.2025.209625_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109107","article-title":"Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020","volume":"229","author":"Cantor","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209625_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3\u20134","key":"10.1016\/j.josat.2025.209625_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/09595237400185281","article-title":"Evaluating the friction of distance parameter in gravity models","volume":"8","author":"Cliff","year":"1974","journal-title":"Regional Studies"},{"key":"10.1016\/j.josat.2025.209625_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109495","article-title":"County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019","volume":"236","author":"Corry","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"author":"FindTreatment.gov","key":"10.1016\/j.josat.2025.209625_bb0055"},{"issue":"9","key":"10.1016\/j.josat.2025.209625_bb0060","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2105\/AJPH.83.9.1289","article-title":"CDC WONDER: A comprehensive on-line public health information system of the Centers for Disease Control and Prevention","volume":"83","author":"Friede","year":"1993","journal-title":"American Journal of Public Health"},{"author":"Geographic Disparities Affect Access to Buprenorphine Services for Opioid Use Disorder","key":"10.1016\/j.josat.2025.209625_bb0065"},{"key":"10.1016\/j.josat.2025.209625_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209182","article-title":"Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine","volume":"156","author":"Gimenez","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209625_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209216","article-title":"Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets","volume":"157","author":"Hsu","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209625_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108534","article-title":"Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis","volume":"220","author":"Iloglu","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"2, Supplement","key":"10.1016\/j.josat.2025.209625_bb0085","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: How to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2025.209625_bb0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","article-title":"Methadone for opioid use disorder\u2014Decades of effectiveness but still miles away in the US","volume":"77","author":"Joudrey","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2025.209625_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7028","article-title":"Assessment of community-level vulnerability and access to medications for opioid use disorder","volume":"5","author":"Joudrey","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209625_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108729","article-title":"Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden","volume":"224","author":"Kazerouni","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2025.209625_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12419","article-title":"Survey of barriers and facilitators to prescribing buprenorphine and clinician perceptions on the drug addiction treatment act of 2000 waiver","volume":"5","author":"Lanham","year":"2022","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.josat.2025.209625_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.18094","article-title":"Analysis of access to prescription data management programs data for research","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2025.209625_bb0115","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.healthplace.2009.06.002","article-title":"An enhanced two-step floating catchment area (E2SFCA) method for measuring spatial accessibility to primary care physicians","volume":"15","author":"Luo","year":"2009","journal-title":"Health & Place"},{"issue":"1","key":"10.1016\/j.josat.2025.209625_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jrh.12300","article-title":"Trends and patterns of opioid analgesic prescribing: Regional and rural-urban variations in Kentucky from 2012 to 2015","volume":"35","author":"Luu","year":"2019","journal-title":"The Journal of Rural Health"},{"key":"10.1016\/j.josat.2025.209625_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209306","article-title":"Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022","volume":"160","author":"Meyerson","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209625_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114992","article-title":"Geographic disparities in access to medication for opioid use disorder across US census tracts based on treatment utilization behavior","volume":"302","author":"Mitchell","year":"2022","journal-title":"Social Science and Medicine"},{"issue":"3","key":"10.1016\/j.josat.2025.209625_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jama.2019.18913","article-title":"Trends in buprenorphine treatment in the United States, 2009-2018","volume":"323","author":"Olfson","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.josat.2025.209625_bb0140","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/24694452.2016.1151336","article-title":"Space\u2013time patterns of rank concordance: Local indicators of mobility association with application to spatial income inequality dynamics","volume":"106","author":"Rey","year":"2016","journal-title":"Annals of the American Association of Geographers"},{"key":"10.1016\/j.josat.2025.209625_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2024.100249","article-title":"Assessing the accuracy of substance use disorder treatment search tools: A cross-sectional analysis of national and state-level directories","volume":"12","author":"Riley","year":"2024","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"6","key":"10.1016\/j.josat.2025.209625_bb0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.15m10386","article-title":"Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States","volume":"77","author":"Saha","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.josat.2025.209625_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108513","article-title":"Medicaid participation among practitioners authorized to prescribe buprenorphine","volume":"133","author":"Saunders","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209625_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209077","article-title":"Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky","volume":"150","author":"Shrestha","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209625_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2023.100164","article-title":"State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements","volume":"7","author":"Silwal","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"key":"10.1016\/j.josat.2025.209625_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108326","article-title":"Community engagement to implement evidence-based practices in the HEALing communities study","volume":"217","author":"Sprague Martinez","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2025.209625_bb0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0132","article-title":"Impact of the communities that HEAL intervention on buprenorphine-waivered practitioners and buprenorphine prescribing: A prespecified secondary analysis of the HCS randomized clinical trial","volume":"7","author":"Stopka","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209625_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109710","article-title":"The prevalence of opioid use disorder in Kentucky\u2019s counties: A two-year multi-sample capture-recapture analysis","volume":"242","author":"Thompson","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"author":"US Census Bureau","key":"10.1016\/j.josat.2025.209625_bb0185"},{"issue":"4","key":"10.1016\/j.josat.2025.209625_bb0190","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.japh.2023.04.016","article-title":"The impact of the mainstreaming addiction treatment act and associated legislative action on pharmacy practice","volume":"63","author":"Varisco","year":"2023","journal-title":"Journal of the American Pharmacists Association"},{"key":"10.1016\/j.josat.2025.209625_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209310","article-title":"Barriers to retention in medications for opioid use disorder treatment in real-world practice","volume":"160","author":"Villamil","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"author":"Vital Statistics Rapid Release\u2014Provisional Drug Overdose Data","key":"10.1016\/j.josat.2025.209625_bb0200"},{"key":"10.1016\/j.josat.2025.209625_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108335","article-title":"The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"Walsh","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2025.209625_bb0210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/0033-0124.00210","article-title":"Modeling commuting patterns in Chicago in a GIS environment: A job accessibility perspective","volume":"52","author":"Wang","year":"2000","journal-title":"The Professional Geographer"},{"key":"10.1016\/j.josat.2025.209625_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108325","article-title":"The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study","volume":"217","author":"Winhusen","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209625_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108331","article-title":"Community dashboards to support data-informed decision-making in the HEALing communities study","volume":"217","author":"Wu","year":"2020","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:44:49Z","timestamp":1741855489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"alternative-id":["S2949875925000049"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209625","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of buprenorphine prescriber data on geospatial access to treatment in HEALing Communities Study communities, 2022","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209625"}}